Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mucopolysaccharidosis Patients in France in the Era of Specific Therapeutics

NCT06036693 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT06036693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06036693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mucopolysaccharidosis Patients in France in the Era of Specific Therapeutics
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Observational
Overall status
Recruiting
Start date
December 20, 2017
Completion date
December 31, 2026
Enrollment
1,000 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis i, mucopolysaccharidosis ii, mucopolysaccharidosis iii, mucopolysaccharidosis iv, mucopolysaccharidosis ix, mucopolysaccharidosis vi, mucopolysaccharidosis vii, multiple sulfatase deficiency disease